{{a.name}} - {{a.desc}} Tab/click for more specific Billable
Sorry, we weren't able to find any results that match your search. Try changing a word or two, or being a little more specific. Thanks!
ICD-10 E70.32 - Oculocutaneous albinism

E70.32

ICD-10 Not billable

Oculocutaneous albinism

Specifically for this code:
  • Chediak-Higashi syndrome (E70.330)
  • Hermansky-Pudlak syndrome (E70.331)
From Section E70-E88:
  • androgen insensitivity syndrome (E34.5-)
  • congenital adrenal hyperplasia (E25.0)
  • Ehlers-Danlos syndrome (Q79.6)
  • hemolytic anemias attributable to enzyme disorders (D55.-)
  • Marfan's syndrome (Q87.4)
  • 5-alpha-reductase deficiency (E29.1)
From Chapter 4:
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)
From Chapter 4:
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E70.32 is a "category code," which means it's non-billable. Billable codes require more specificity. Use the list below to navigate to codes that are more specific:
10
E70.320
Tyrosinase negative oculocutaneous albinism
Billable
10
E70.321
Tyrosinase positive oculocutaneous albinism
Billable
10
E70.328
Other oculocutaneous albinism
Billable
10
E70.329
Oculocutaneous albinism, unspecified
Billable
      
Showing results for: {{searchResults.terms}}
More results: